malondialdehyde has been researched along with Fatty Liver with Encephalopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdin, A; Sarhan, N | 1 |
| Crocker, JF; Her, H; Jollimore, C; Murphy, MG | 1 |
| Kohlman, L; Larroya, S; Morrison, A; Schwarz, KB | 1 |
3 other study(ies) available for malondialdehyde and Fatty Liver with Encephalopathy
| Article | Year |
|---|---|
Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.
Topics: Ammonia; Animals; Antioxidants; Electron Transport Complex I; Fatty Acids, Monounsaturated; Malondialdehyde; Membrane Transport Proteins; Oxidative Stress; Prothrombin; Rats, Wistar; Resveratrol; Reye Syndrome; Serum Albumin; Serum Albumin, Human; Stilbenes; Transaminases | 2014 |
Beta-oxidation of [1-14C]palmitic acid by mouse astrocytes in primary culture: effects of agents implicated in the encephalopathy of Reye's syndrome.
Topics: Ammonia; Animals; Animals, Newborn; Astrocytes; Body Water; Cells, Cultured; Child; Child, Preschool; Humans; Infant; Lipid Metabolism; Lipid Peroxidation; Malondialdehyde; Mice; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Proteins; Reye Syndrome; Triglycerides; Xenobiotics | 1992 |
Erythrocyte lipid abnormalities in Reye's syndrome.
Topics: Child; Cholesterol; Erythrocytes; Fatty Acids; Humans; Lipids; Malondialdehyde; Phospholipids; Reye Syndrome; Vitamin E | 1987 |